America as we know it was built largely upon and because of our rail industry, and today it remains…
So-Called "Railway Safety Act" Constitutes a Political Handout to Big Labor That Does Nothing to Improve Safety At All
America as we know it was built largely upon and because of our rail industry, and today it remains a pillar of our economy.
Unfortunately, a destructive proposal before Congress misleadingly named the "Railway Safety Act" (RSA), part of broader surface transportation reauthorization, threatens great harm to our railroads.
Simply put, the bill has nothing to do with improving safety, but has a lot to do with advancing the political agenda of Big Labor. At a moment when inflation burdens American families and fragile supply chains remain vulnerable to disruption, the last thing our economy or rail sector need is another costly federal mandate imposed upon one of the nation’s most important transportation sectors.
As an initial matter, as noted by The Wall Street Journal, the…[more]
Ryan Wiggins, Owner and Chief Strategist for Full Contact Strategies, LLC, discusses the role of a political media consultant in the legislative process and the big issues facing Florida and other state legislatures, including Medicaid expansion, mental health, prison reform and medical marijuana.
Sally Pipes, Founder, CEO and President of the Pacific Research Institute, discusses the biggest healthcare takeaways from a numbers perspective in the recently enacted “Big Beautiful Bill,” how cheap drugs from Canada can’t make America healthy, and the real culprit impeding drug competition.
Thomas Aiello, Senior Director of Government Affairs at the National Taxpayers Union, discusses the uphill battle President Trump’s “Big Beautiful Bill” is facing on Capitol Hill, the looming July 4th deadline, and how the battle in the Senate may ultimately result in improvements to the House version of the bill.
William J. Conti, a former law partner in the Washington, DC, office of Baker & Hostetler, discusses who's running, who’s likely running, and who's not running for president in 2024, and some of the issues that may impact the candidates' chances of winning the nomination and the election.
Scott Blackburn, Research Director at the Institute for Free Speech, discusses a first-of-its-kind report that grades the freedom of citizens and advocacy groups in each state to speak about candidates, government and issues of public policy, which states performed poorly, and which states earned a respectable score.
Timothy Lee, CFIF's Senior Vice President of Legal and Public Affairs, discusses the potential real world costs of prescription drug price controls, including lost lives, shortages and innovation disincentives, and how drug prices are weathering the inflation storm.
Sally Pipes, Thomas W. Smith Fellow in Health Care Policy and President and CEO of the Pacific Research Institute, discusses why partially expanding Medicaid is a bad idea, for both fiscal and moral reasons, and what "Medicare-for-All" really would mean for Americans and the economy.